Two cheers for inhaled insulin

Same author

Insulin lispro: a new quick-acting insulin analogue.

Expert opinion on investigational drugs·2005

Same author

Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study.

British journal of cancer·2005

Same author

[Thiazolidinediones--new antidiabetic agents. Why don't we know how to use them?].

Ugeskrift for laeger·2002

Same author

Does partial preservation of residual beta-cell function justify immune intervention in recent onset Type I diabetes?

Diabetologia·2001

Same author

Reanalysis of twin studies suggests that diabetes is mainly genetic.

BMJ (Clinical research ed.)·2001

Same author

Lessons from the glitazones: a story of drug development.

Lancet (London, England)·2001

Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026

Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026

Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026

Same journal

Documenting hospice care.

Lancet (London, England)·2026

Same journal

After the wood chipper.

Lancet (London, England)·2026

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Related Experiment Videos

Two cheers for inhaled insulin

Related Concept Videos

Insulin lispro: a new quick-acting insulin analogue.

Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study.

[Thiazolidinediones--new antidiabetic agents. Why don't we know how to use them?].

Does partial preservation of residual beta-cell function justify immune intervention in recent onset Type I diabetes?

Reanalysis of twin studies suggests that diabetes is mainly genetic.

Lessons from the glitazones: a story of drug development.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.

Related Experiment Videos

Two cheers for inhaled insulin

Related Concept Videos

Related Articles

Insulin lispro: a new quick-acting insulin analogue.

Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study.

[Thiazolidinediones--new antidiabetic agents. Why don't we know how to use them?].

Does partial preservation of residual beta-cell function justify immune intervention in recent onset Type I diabetes?

Reanalysis of twin studies suggests that diabetes is mainly genetic.

Lessons from the glitazones: a story of drug development.

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.